Remedy reports revenue declines in Q2 and H1 as it prepares for Control Resonant launch
Remedy reported revenue declines in the first half and second quarter of 2026 while increasing marketing efforts for Control Resonant.
点赞
收藏
点踩
分享评论
?
参与讨论
Remedy reported revenue declines in the first half and second quarter of 2026 while increasing marketing efforts for Control Resonant.